글로벌 관절염 시장 – 2030년까지의 산업 동향 및 예측

관절염 시장 분석 및 규모:

관절염의 유병률 증가와 기술의 발전으로 관절염 치료의 설계와 기능이 크게 개선되었고 관절염 시장 성장의 길을 개척했습니다. 관절염 시장은 여러 요인으로 인해 꾸준히 성장해 왔습니다. 첫째, 관절염에 대한 새롭고 개선된 치료 옵션을 개발하는 것이 시장의 원동력이 되었습니다. 또한 관절염 치료에 있어 개인화된 의학에 대한 관심이 점차 높아지고 있습니다.

Data Bridge Market Research는 2022년에 43억 달러였던 글로벌 관절염 시장이 2030년까지 86억 3천만 달러로 급증할 것이며 예측 기간 동안 9.10%의 CAGR을 기록할 것으로 분석했습니다. 이는 생물학적 제제 부문이 관절염 시장의 류마티스 약물 유형 부문을 지배하고 있음을 나타냅니다. 기술의 발전으로 다양한 용도의 신속하고 이식 가능한 약물과 치료법이 개발되었습니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

관절염 시장 범위 및 세분화

시장 정의

글로벌 관절염 시장은 관절염의 진단, 치료 및 관리와 관련된 상업적, 치료적 환경을 말합니다. 관절염은 관절의 염증과 경직을 특징으로 하는 근골격계 질환입니다. 관절염은 모든 연령대의 사람들에게 영향을 미쳐 통증, 운동 장애 및 삶의 질 저하를 유발하는 만연한 만성 질환입니다.

글로벌 관절염 시장은 의약품, 생물학, 의료 기기 , 진단 도구 , 지지 요법 을 포함하여 관절염 환자의 요구를 해결하는 것을 목표로 하는 다양한 제품과 서비스를 포함합니다 . 또한 연구 개발 활동, 임상 시험 , 관절염 치료와 관련된 규제 프레임워크 도 포함됩니다 .

글로벌 관절염 시장 동향

운전자

• 관절염 유병률 증가

The rising prevalence of arthritis, including rheumatoid arthritis, osteoarthritis, and psoriatic arthritis, is a significant market driver. Factors such as aging populations, sedentary lifestyles, obesity, and genetic predisposition contribute to the growing number of arthritis cases worldwide.

• Growing Awareness and Diagnostics

There is an increasing awareness of arthritis and its impact on individuals' quality of life. This has led to improved diagnosis rates and early detection of the disease. Greater awareness among both patients and healthcare professionals helps in timely intervention and treatment, driving the demand for arthritis management solutions.

• Advancements Treatment Options

The arthritis market has witnessed significant advancements in treatment options, including pharmacological interventions, biological therapies, and non-pharmacological approaches such as physical therapy and exercise. These innovations have improved the management of arthritis, providing patients with more effective and personalized treatment options.

Opportunities

• Rising Biologic Therapies

Biologic therapies, such as tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, and Janus kinase (J.A.K.) inhibitors, have revolutionized the treatment of arthritis. However, there is still room for improvement in efficacy, safety, and personalized treatment options. Developing innovative biologics with improved efficacy and reduced side effects can be a significant opportunity in the market.

• Rising Patient Education and Support:

Arthritis is a chronic condition that requires self-management and lifestyle modifications. Providing education, support, and resources to patients and their caregivers can improve treatment adherence and outcomes. Digital health platforms, mobile applications, and telemedicine services can significantly deliver patient education and support.

Restraints/Challenges

• High Treatment Costs

Arthritis management often requires long-term medication and therapy, which can be expensive. The high cost of treatment, including prescription medications, physical therapy, and surgeries, can be a significant barrier for patients, particularly in countries with limited access to healthcare or inadequate insurance coverage. Affordability issues can hinder patients' ability to receive necessary treatment and limit market growth.

• Limited Efficacy of Available Treatments

While various treatment options are available for arthritis, including non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and biologic therapies, not all patients respond adequately to these treatments. Some patients may experience only partial relief of symptoms or no improvement at all. The limited efficacy of existing treatments can restrict market growth and drive the need for innovative therapies.

This global arthritis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global arthritis market contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed decision to achieve market growth.

Recent Development

• In December 2022, Merck KGaA, a leading science and technology company, announced a research collaboration and commercial license agreement with Mersana Therapeutics, Inc., Cambridge, Massachusetts, U.S.A, to discover novel antibody-drug conjugates (A.D.C.s) leveraging Mersana's proprietary Immunosynthen STING-agonist A.D.C. platform, directed against up to two targets
• In February 2023, Roche announced that it had expanded its collaboration with Janssen Biotech Inc. (Janssen) to create companion diagnostics for targeted therapies, further strengthening research and innovation activities

Global Arthritis Market Scope

The global arthritis market is segmented on the basis of Rheumatoid Drug Type, Rheumatoid Treatment, Rheumatoid Diagnosis, Osteoarthritis Type, Osteoarthritis Treatment, Osteoarthritis Diagnosis, Route of Administration, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Rheumatoid Drug Type

• Biologics
• Non-Biologics
• Steroids
• Analgesics
• Glucocorticoids
• Others

Rheumatoid Treatment

• Synovectomy
• Tendon Repair
• Joint Fusion
• Symptomatic Treatment
• Intermediate Corticosteroid Therapies
• DMARD Therapies

Rheumatoid Diagnosis

• C.R.P. Test
• CCP
• ESR Test

Osteoarthritis Type

• Hip
• Spinal
• Knee
• Foot and Ankle
• Shoulder
• Hand

Osteoarthritis Treatment

• Medication
• Drugs
• Assistive Devices
• Surgery
• Therapy

Osteoarthritis Diagnosis

• Imaging
• Joint Fluid Analysis
• Others

Route of Administration

• Oral
• Parenteral

End user

• Hospitals,
• Clinics
• Household
• Medical Institutes
• Research Organizations,
• Others

Global Arthritis Market Regional Analysis/Insights

The global arthritis market is analyzed, and market size insights and trends are provided for product type, biomaterial, procedure, device type, application, and end-user, as referenced above.

The countries covered in the global arthritis market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, the Rest of South America, Germany, France, the U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of the Middle East and Africa.

North America dominates the arthritis market due to the presence of major key players, high disposable income, high healthcare expenditure, and a well-developed healthcare sector in this region.

 Asia-Pacific is expected to grow during the forecast period of 2023-2030 due to the increasing research and development activities, rising investment in the healthcare sector, and growing government support.

The country section of the report also provides individual market-impacting factors and domestic regulation changes that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends and Porter’s five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global arthritis market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the Global arthritis market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the Global arthritis market. The data is available for the historical period 2015-2020.

Competitive Landscape and Global Arthritis Market Share Analysis

The global arthritis market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the global arthritis market.

Some of the major players operating in the global arthritis market are:

• Johnson & Johnson Private Limited(U.S.)
• AbbVie Inc. (U.S.)
• Pfizer Inc. (U.S.)
• Amgen Inc. (U.S.)
• Bristol-Myers Squibb Company(U.S.)
• F. Hoffmann-La Roche Ltd.(U.S.)
• UCB S.A.(Belgium)
• Gilead Sciences, Inc. (U.S.)
•  베링거인겔하임인터내셔널(독일)
• 릴리(미국)
• 사노피(프랑스)
• 노바티스 AG(스위스)
• 아스트라제네카(미국)
•  아스텔라스파마 주식회사(일본)
• 갈라파고스 NV(벨기에)
• 다이쇼제약홀딩스 주식회사(영국)
• Regeneron Pharmaceuticals Inc.(미국)
• Swedish Orphan Biovitrum AB (publ) (스웨덴)
• ABIOGEN PHARMA SpA(이탈리아)
•  코오롱티슈진(주)(US)
• Ampio Pharmaceuticals Inc.(미국)
• Merck Sharp & Dohme Corp.(미국),
• GlaxoSmithKline plc (영국)

SKU-50145